Skip to content
Browse

Edition

Sections

Appearance

AboutSourcesContactPrivacy

Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom?

Novonesis is exploring whether gut health supplements could benefit patients taking GLP-1 weight-loss drugs, opening up a potentially lucrative new market.

First reported by CNBC 1 source
Read at CNBC(opens in a new tab)

Full coverage

Every report we found on this story, oldest first. Each links to the original publisher.

  1. CNBC

    Could supplements be the next big opportunity in the GLP-1 weight-loss drug boom? (opens CNBC in a new tab)

    Novonesis is exploring whether gut health supplements could benefit patients taking GLP-1 weight-loss drugs, opening up a potentially lucrative new market.

Something wrong with how we've grouped or summarised this story? Report a problem